Hemispherx Biopharma (HEB) 3rd Quarter 2009 Financial Results
11/9/2009 1:36:51 PM
More...
|
Hemispherx Biopharma (HEB) Responding to FDA's Ampligen Questions
11/3/2009 7:50:42 AM
More...
|
Hemispherx Biopharma (HEB) Updates Chronic Fatigue Syndrome (CFS) Treatment and Commercial Application Programs
11/2/2009 8:44:28 AM
More...
|
Hemispherx Biopharma (HEB) Release: Japanese National Institutes of Health (NIH) Expands Pandemic Flu Protective Potential by Ampligen(R)
10/26/2009 8:37:06 AM
More...
|
Hemispherx Biopharma (HEB) Release: Japanese National Institutes of Health (NIH) Research Reaffirms and Expands Pandemic Flu Protection by Ampligen(R)
10/15/2009 8:36:52 AM
More...
|
Hemispherx Biopharma (HEB) Release: New Infectious Retrovirus Detected in Chronic Fatigue Syndrome
10/13/2009 8:15:40 AM
More...
|
BioMedReports Interview With Hemispherx Biopharma (HEB)'s Chief Executive Officer, Dr. William A. Carter
10/9/2009 8:24:37 AM
More...
|
Hemispherx Biopharma (HEB)'s Ampligen(R)/ Intranasal Flu Vaccine Program to be Presented At International Vaccine Workshop in Osaka
10/8/2009 8:39:43 AM
More...
|
Stanford University Presents New Data On Immuno-Potential of Hemispherx Biopharma (HEB)'s Ampligen(R)
10/1/2009 9:43:03 AM
More...
|
Hemispherx Biopharma (HEB) Presents At the Maxim Group Annual Growth Conference
9/23/2009 9:39:10 AM
More...
|
|